Bionomics Limited participates in forthcoming investor promotion in November…
ADELAIDE, Australia, Nov. 02, 2022 (GLOBE NEWSWIRE) — Bionomics Limited BNOXBNO)) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel allosteric ion channel modulators that